Schedule 13G ownership disclosure

ADVERUM BIOTECHNOLOGIES INC

Common Stock, $0.0001 par value · CUSIP: 00773U207

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 0.00 · Class: 0.0%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 0.00 · Class: 0.0%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 0.00 · Class: 0.0%

  • VHCP Management III, LLC

    Shares: 0.00 · Class: 0.0%

  • VHCP Management EG, LLC

    Shares: 0.00 · Class: 0.0%

  • Nimish Shah

    Shares: 0.00 · Class: 0.0%

  • Bong Y Koh

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-004239
Form type
SCHEDULE 13G/A
Filer
Adverum Biotechnologies, Inc.
CIK
CIK 1501756
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub